Latest Tissue plasminogen activator Stories
TPAs in General Have Difficulties in Forecasting the Costs and Pricing of their Products Park City, UT (PRWEB) February 05, 2013 Today, Zane Benefits,
People having an ischemic stroke should receive clot-dissolving therapy – if appropriate -- within 60 minutes of arriving at the hospital.
Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage.
Stroke is the fourth leading cause of death and a common cause of long-term disability in the United States, but doctors have very few proven treatment methods.
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke.
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI).
Researchers from the Duke Clinical Research Institute have ruled the clot-busting drug tPA (tissue plasminogen activator) safe for acute stroke patients on the home blood thinner warfarin.